Limits...
Ultrasound-targeted stromal cell-derived factor-1-loaded microbubble destruction promotes mesenchymal stem cell homing to kidneys in diabetic nephropathy rats.

Wu S, Li L, Wang G, Shen W, Xu Y, Liu Z, Zhuo Z, Xia H, Gao Y, Tan K - Int J Nanomedicine (2014)

Bottom Line: The related bioeffects were also elucidated.In the in vivo study, SDF-1 was successfully released in the targeted kidneys.In conclusion, ultrasound-targeted MB(SDF-1) destruction could promote the homing of MSCs to early DN kidneys and provide a novel potential therapeutic approach for DN kidney repair.

View Article: PubMed Central - PubMed

Affiliation: Department of Ultrasound, Third Military Medical University, Chongqing, People's Republic of China.

ABSTRACT
Mesenchymal stem cell (MSC) therapy has been considered a promising strategy to cure diabetic nephropathy (DN). However, insufficient MSCs can settle in injured kidneys, which constitute one of the major barriers to the effective implementation of MSC therapy. Stromal cell-derived factor-1 (SDF-1) plays a vital role in MSC migration and involves activation, mobilization, homing, and retention, which are presumably related to the poor homing in DN therapy. Ultrasound-targeted microbubble destruction has become one of the most promising strategies for the targeted delivery of drugs and genes. To improve MSC homing to DN kidneys, we present a strategy to increase SDF-1 via ultrasound-targeted microbubble destruction. In this study, we developed SDF-1-loaded microbubbles (MB(SDF-1)) via covalent conjugation. The characterization and bioactivity of MB(SDF-1) were assessed in vitro. Target release in the targeted kidneys was triggered with diagnostic ultrasound in combination with MB(SDF-1). The related bioeffects were also elucidated. Early DN was induced in rats with streptozotocin. Green fluorescent protein-labeled MSCs were transplanted intravenously following the target release of SDF-1 in the kidneys of normal and DN rats. The homing efficacy was assessed by detecting the implanted exogenous MSCs at 24 hours. The in vitro results showed an impressive SDF-1 loading efficacy of 79% and a loading content of 15.8 μg/mL. MB(SDF-1) remained bioactive as a chemoattractant. In the in vivo study, SDF-1 was successfully released in the targeted kidneys. The homing efficacy of MSCs to DN kidneys after the target release of SDF-1 was remarkably ameliorated at 24 hours compared with control treatments in normal rats and DN rats. In conclusion, ultrasound-targeted MB(SDF-1) destruction could promote the homing of MSCs to early DN kidneys and provide a novel potential therapeutic approach for DN kidney repair.

Show MeSH

Related in: MedlinePlus

SDF-1 expression by immunohistochemistry.Notes: The immunohistochemistry for the renal expression of SDF-1 significantly differed between normal rats and early DN rats. Positive expression was found in DN rats, compared with negative expression in normal rats. The positive expression was brown in the cytoplasm.Abbreviations: SDF-1, stromal cell-derived factor-1; DN, diabetic nephropathy.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4263441&req=5

f7-ijn-9-5639: SDF-1 expression by immunohistochemistry.Notes: The immunohistochemistry for the renal expression of SDF-1 significantly differed between normal rats and early DN rats. Positive expression was found in DN rats, compared with negative expression in normal rats. The positive expression was brown in the cytoplasm.Abbreviations: SDF-1, stromal cell-derived factor-1; DN, diabetic nephropathy.

Mentions: The brown area was the positive expression of SDF-1. The expression localized to the cytoplasm. SDF-1 was slightly expressed in tubules and rarely expressed in the glomeruli of DN kidneys. In comparison, SDF-1 expression was occasionally visualized in normal kidneys (Figure 7). The IOD of SDF-1expression was obviously higher in DN kidneys (IOD value of 35,762±4,541) than that of normal kidneys (IOD value of 2,994±854).


Ultrasound-targeted stromal cell-derived factor-1-loaded microbubble destruction promotes mesenchymal stem cell homing to kidneys in diabetic nephropathy rats.

Wu S, Li L, Wang G, Shen W, Xu Y, Liu Z, Zhuo Z, Xia H, Gao Y, Tan K - Int J Nanomedicine (2014)

SDF-1 expression by immunohistochemistry.Notes: The immunohistochemistry for the renal expression of SDF-1 significantly differed between normal rats and early DN rats. Positive expression was found in DN rats, compared with negative expression in normal rats. The positive expression was brown in the cytoplasm.Abbreviations: SDF-1, stromal cell-derived factor-1; DN, diabetic nephropathy.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4263441&req=5

f7-ijn-9-5639: SDF-1 expression by immunohistochemistry.Notes: The immunohistochemistry for the renal expression of SDF-1 significantly differed between normal rats and early DN rats. Positive expression was found in DN rats, compared with negative expression in normal rats. The positive expression was brown in the cytoplasm.Abbreviations: SDF-1, stromal cell-derived factor-1; DN, diabetic nephropathy.
Mentions: The brown area was the positive expression of SDF-1. The expression localized to the cytoplasm. SDF-1 was slightly expressed in tubules and rarely expressed in the glomeruli of DN kidneys. In comparison, SDF-1 expression was occasionally visualized in normal kidneys (Figure 7). The IOD of SDF-1expression was obviously higher in DN kidneys (IOD value of 35,762±4,541) than that of normal kidneys (IOD value of 2,994±854).

Bottom Line: The related bioeffects were also elucidated.In the in vivo study, SDF-1 was successfully released in the targeted kidneys.In conclusion, ultrasound-targeted MB(SDF-1) destruction could promote the homing of MSCs to early DN kidneys and provide a novel potential therapeutic approach for DN kidney repair.

View Article: PubMed Central - PubMed

Affiliation: Department of Ultrasound, Third Military Medical University, Chongqing, People's Republic of China.

ABSTRACT
Mesenchymal stem cell (MSC) therapy has been considered a promising strategy to cure diabetic nephropathy (DN). However, insufficient MSCs can settle in injured kidneys, which constitute one of the major barriers to the effective implementation of MSC therapy. Stromal cell-derived factor-1 (SDF-1) plays a vital role in MSC migration and involves activation, mobilization, homing, and retention, which are presumably related to the poor homing in DN therapy. Ultrasound-targeted microbubble destruction has become one of the most promising strategies for the targeted delivery of drugs and genes. To improve MSC homing to DN kidneys, we present a strategy to increase SDF-1 via ultrasound-targeted microbubble destruction. In this study, we developed SDF-1-loaded microbubbles (MB(SDF-1)) via covalent conjugation. The characterization and bioactivity of MB(SDF-1) were assessed in vitro. Target release in the targeted kidneys was triggered with diagnostic ultrasound in combination with MB(SDF-1). The related bioeffects were also elucidated. Early DN was induced in rats with streptozotocin. Green fluorescent protein-labeled MSCs were transplanted intravenously following the target release of SDF-1 in the kidneys of normal and DN rats. The homing efficacy was assessed by detecting the implanted exogenous MSCs at 24 hours. The in vitro results showed an impressive SDF-1 loading efficacy of 79% and a loading content of 15.8 μg/mL. MB(SDF-1) remained bioactive as a chemoattractant. In the in vivo study, SDF-1 was successfully released in the targeted kidneys. The homing efficacy of MSCs to DN kidneys after the target release of SDF-1 was remarkably ameliorated at 24 hours compared with control treatments in normal rats and DN rats. In conclusion, ultrasound-targeted MB(SDF-1) destruction could promote the homing of MSCs to early DN kidneys and provide a novel potential therapeutic approach for DN kidney repair.

Show MeSH
Related in: MedlinePlus